Skip to main content
EKF DIAGNOSTICS HOLDINGS PLC logo

EKF DIAGNOSTICS HOLDINGS PLC — Investor Relations & Filings

Ticker · EKF ISIN · GB0031509804 LEI · 213800DXTF3EAUK1AR05 IL Manufacturing
Open in API
Filings indexed 532 across all filing types
Latest filing 2021-11-08 Director's Dealing
Country GB United Kingdom
Listing IL EKF

About EKF DIAGNOSTICS HOLDINGS PLC

https://www.ekfdiagnostics.com/

EKF Diagnostics Holdings plc is a global in-vitro diagnostics (IVD) and biotechnology company that develops, manufactures, and distributes medical technologies. The company provides solutions for both point-of-care (POC) and central laboratory settings. Its product portfolio includes a range of analyzers, reagents, and tests for critical parameters such as hemoglobin, HbA1c, glucose, and lactate, which are used for the early detection, diagnosis, and monitoring of various conditions. EKF also offers products for life sciences applications, supporting therapeutic development and high-throughput analysis. The company is focused on delivering reliable, accurate, and cost-effective diagnostic tools to empower healthcare professionals and enhance patient outcomes.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 99% confidence The document is an official announcement filed with RNS (RNS Number: 6822R) dated November 8, 2021. The content explicitly details a 'Director/PDMR Shareholding' transaction, specifically a sale of Ordinary Shares by Julian Baines, the Non-Executive Deputy Chairman. This type of filing, reporting personal share transactions by company directors and executives, directly corresponds to the definition of 'Director's Dealing' (Code: DIRS). Although it is distributed via RNS, the specific nature of the content makes DIRS the most accurate classification over the general RNS fallback.
2021-11-08 English
Dividend confirmation
Notice of Dividend Amount Classification · 99% confidence The document explicitly announces a 'Dividend confirmation' detailing the amount (1.1p per ordinary share) and the associated timetable (Ex-dividend date, Record date, Payment date). This directly corresponds to the definition of a Notice of Dividend Amount. The presence of the RNS Number and the closing statement referencing RNS as the primary information provider confirms it is a regulatory announcement, but the specific content points overwhelmingly to the DIV code.
2021-10-25 English
Completion of ADL Health Acquisition
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated '12 October 2021'. It announces the 'Completion of acquisition, Admission & TVR Update' following a previous announcement, detailing the admission of 'Consideration Shares' to trading on AIM and updating the 'Total Voting Rights' based on the Financial Conduct Authority's Disclosure Guidance and Transparency Rules (DTRs). The footer explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This structure and source strongly indicate a general regulatory announcement disseminated via the RNS system, which aligns best with the 'Regulatory Filings' category (RNS) as a catch-all for official, non-specific regulatory news releases.
2021-10-12 English
PDMR/ PCA Dealings
Director's Dealing Classification · 100% confidence The document is an official announcement filed via RNS (RNS Number: 0981O) dated October 5, 2021. The content explicitly details a 'PDMR/ PCA Dealings' notification, specifically reporting the sale of shares by the Non-executive Chairman, Christopher Mills, and related entities. This falls directly under the definition of reporting personal share transactions by company directors and executives, which corresponds to the 'Director's Dealing' category.
2021-10-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is identified by the 'RNS Number' header and the explicit mention of 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content is a 'TR-1: Standard form for notification of major holdings,' which details changes in voting rights held by an entity (Harwood Capital Management (Gibraltar) Limited and associated parties) in EKF Diagnostics Holdings PLC. This type of filing, reporting changes in significant share ownership thresholds, directly corresponds to the Major Shareholding Notification category (MRQ). Although it is distributed via RNS, the specific content dictates the MRQ classification over the general RNS fallback.
2021-10-05 English
Acquisition of Advanced Diagnostic Laboratory LLC
M&A Activity Classification · 99% confidence The document begins with 'RNS Number : 1393N' and contains language typical of regulatory announcements on the London Stock Exchange's RNS system, including a disclaimer about 'INSIDE INFORMATION FOR THE PURPOSES OF THE UK VERSION OF THE MARKET ABUSE REGULATION'. The content details a significant corporate action: the acquisition of 'Advanced Diagnostic Laboratory LLC' for an initial payment in shares, with performance-based earnouts. This is a material event announcement. Since the document is a formal announcement of a major transaction (M&A activity) released via the RNS system, the most specific category is 'M&A Activity' (TAR). However, the document is clearly an official regulatory news service release, which often falls under the general 'RNS' category if a more specific one isn't available or if the primary function is the dissemination itself. Given the detailed nature of the M&A announcement, TAR is highly relevant. But looking at the definitions, 'TAR' is for 'Merger proposals or takeover bids'. This is an acquisition announcement. Since it is explicitly distributed via RNS and contains standard RNS boilerplate, and the core event is a transaction, I must choose the best fit. The transaction is an acquisition, which is a type of M&A activity. If TAR is strictly for proposals/bids, this completed agreement might fit better under a general regulatory filing (RNS) or perhaps a Capital/Financing Update (CAP) due to the share issuance, but the primary subject is the acquisition. Given the structure and the explicit RNS header, RNS is a safe classification, but TAR (M&A Activity) is the most descriptive of the *content*. Since the document is a full announcement, not just a notice of publication, I will classify it as M&A Activity (TAR).
2021-09-28 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.